Annual Total Assets
$167.90 M
+$63.99 M+61.58%
December 31, 2023
Summary
- As of February 12, 2025, QNCX annual total assets is $167.90 million, with the most recent change of +$63.99 million (+61.58%) on December 31, 2023.
- During the last 3 years, QNCX annual total assets has fallen by -$21.57 million (-11.38%).
- QNCX annual total assets is now -11.38% below its all-time high of $189.47 million, reached on December 31, 2020.
Performance
QNCX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$126.52 M
-$8.31 M-6.16%
September 30, 2024
Summary
- As of February 12, 2025, QNCX quarterly total assets is $126.52 million, with the most recent change of -$8.31 million (-6.16%) on September 30, 2024.
- Over the past year, QNCX quarterly total assets has dropped by -$41.38 million (-24.65%).
- QNCX quarterly total assets is now -45.28% below its all-time high of $231.21 million, reached on March 31, 2020.
Performance
QNCX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
QNCX Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.6% | -24.6% |
| 3 y3 years | -11.4% | -24.6% |
| 5 y5 years | +130.4% | -24.6% |
QNCX Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.6% | -24.6% | +48.2% |
| 5 y | 5-year | -11.4% | +61.6% | -45.3% | +48.2% |
| alltime | all time | -11.4% | +2075.4% | -45.3% | +79.2% |
Quince Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $126.52 M(-6.2%) |
| Jun 2024 | - | $134.83 M(-15.4%) |
| Mar 2024 | - | $159.29 M(-5.1%) |
| Dec 2023 | $167.90 M(+61.6%) | $167.90 M(+96.6%) |
| Sep 2023 | - | $85.39 M(-3.9%) |
| Jun 2023 | - | $88.84 M(-4.8%) |
| Mar 2023 | - | $93.32 M(-10.2%) |
| Dec 2022 | $103.91 M(-22.0%) | $103.91 M(-5.3%) |
| Sep 2022 | - | $109.78 M(-6.9%) |
| Jun 2022 | - | $117.86 M(+1.5%) |
| Mar 2022 | - | $116.13 M(-12.8%) |
| Dec 2021 | $133.23 M | $133.23 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $147.42 M(-8.7%) |
| Jun 2021 | - | $161.39 M(-7.5%) |
| Mar 2021 | - | $174.52 M(-7.9%) |
| Dec 2020 | $189.47 M(+52.3%) | $189.47 M(-7.4%) |
| Sep 2020 | - | $204.66 M(-6.6%) |
| Jun 2020 | - | $219.21 M(-5.2%) |
| Mar 2020 | - | $231.21 M(+85.9%) |
| Dec 2019 | $124.37 M(+70.7%) | $124.37 M(-6.8%) |
| Sep 2019 | - | $133.41 M(-6.9%) |
| Jun 2019 | - | $143.24 M(+102.9%) |
| Mar 2019 | - | $70.60 M(-3.1%) |
| Dec 2018 | $72.88 M(+844.2%) | $72.88 M |
| Dec 2017 | $7.72 M | - |
FAQ
- What is Quince Therapeutics annual total assets?
- What is the all time high annual total assets for Quince Therapeutics?
- What is Quince Therapeutics annual total assets year-on-year change?
- What is Quince Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Quince Therapeutics?
- What is Quince Therapeutics quarterly total assets year-on-year change?
What is Quince Therapeutics annual total assets?
The current annual total assets of QNCX is $167.90 M
What is the all time high annual total assets for Quince Therapeutics?
Quince Therapeutics all-time high annual total assets is $189.47 M
What is Quince Therapeutics annual total assets year-on-year change?
Over the past year, QNCX annual total assets has changed by +$63.99 M (+61.58%)
What is Quince Therapeutics quarterly total assets?
The current quarterly total assets of QNCX is $126.52 M
What is the all time high quarterly total assets for Quince Therapeutics?
Quince Therapeutics all-time high quarterly total assets is $231.21 M
What is Quince Therapeutics quarterly total assets year-on-year change?
Over the past year, QNCX quarterly total assets has changed by -$41.38 M (-24.65%)